financetom
Business
financetom
/
Business
/
What's Going On With Bank Of America Shares?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Bank Of America Shares?
Apr 12, 2024 11:37 AM

Bank of America Corp ( BAC ) shares are trading lower by 1.3% to $35.88 during Friday’s session. Shares of several companies in the broader financial sector are trading lower after a number of major U.S. banks reported first-quarter earnings and amid overall market weakness.

What Happened?

Five major U.S. financial institutions reported their first-quarter financial results, exceeding expectations for both earnings and revenue. This highlights the favorable conditions for banks due to rising interest rates and a strong economy.

JPMorgan Chase & Co. particularly stood out, with earnings per share (EPS) of $4.44 and revenue of $42.55 billion, surpassing the expected $41.836 billion. Despite slightly lower loans than expected, the bank showed resilience with lower provision for credit losses compared to estimates…

Is BAC A Good Stock To Buy?

An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like Bank of America ( BAC )‘s page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.

These are known as capital allocation programs. Bank of America ( BAC ) does pay a dividend, which yields 3.1% per year as of the closing price on Apr. 12, 2024. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.

For example, if you're looking to earn an annualized return of 16.59%, you'll need to buy a share of Orchid Island Cap by the Apr. 29, 2024. Once done, you can expect to receive a nominal payout of $0.12 on May. 30, 2024.

Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on Bank of America ( BAC ) will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.

According to data from Benzinga Pro, BAC has a 52-week high of $38.35 and a 52-week low of $24.96.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Glatfelter Shareholders Approve Proposals Related To The Proposed Merger Of Berry'S Health, Hygiene And Specialties Global Nonwovens And Films Business With Glatfelter
BRIEF-Glatfelter Shareholders Approve Proposals Related To The Proposed Merger Of Berry'S Health, Hygiene And Specialties Global Nonwovens And Films Business With Glatfelter
Oct 23, 2024
Oct 23 (Reuters) - Berry Global Group Inc ( BERY ): * GLATFELTER SHAREHOLDERS APPROVE PROPOSALS RELATED TO THE PROPOSED MERGER OF BERRY'S HEALTH, HYGIENE AND SPECIALTIES GLOBAL NONWOVENS AND FILMS BUSINESS WITH GLATFELTER Source text for Eikon: Further company coverage: ...
Life Time Group Holdings Unit Prices Upsized $500 Million Private Offering
Life Time Group Holdings Unit Prices Upsized $500 Million Private Offering
Oct 23, 2024
08:40 AM EDT, 10/23/2024 (MT Newswires) -- Life Time Group Holdings ( LTH ) said Wednesday its Life Time subsidiary has priced a private offering of $500 million of 6% senior secured notes due 2031. The offering, which was upsized from $400 million, is expected to close Nov. 5. Life Time also plans to amend its existing credit agreement to...
Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 billion
Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 billion
Oct 23, 2024
(Reuters) - Merck ( MRK ) has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday. As part of the deal, the U.S. drugmaker paid $30 million upfront. Modifi is also eligible to receive potential milestone payments of up to $1.3 billion in exchange for...
Boeing Q3 Earnings: Revenue And Profit Decline, Cultural Challenges, CEO Ortberg Vows Transformation
Boeing Q3 Earnings: Revenue And Profit Decline, Cultural Challenges, CEO Ortberg Vows Transformation
Oct 23, 2024
Boeing Co ( BA ) reported a 1% year-over-year revenue decline to $17.854 billion in the third quarter of 2024, missing the consensus of $17.931 billion. Adjusted loss per share expanded to $10.44 from $3.62 in the same quarter of 2023, missing the consensus of $10.34. The company stated that the results reflect the impact of the International Association of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved